经皮主动脉瓣置换术将成为主动脉瓣疾病的一种常见治疗方法。

Percutaneous aortic valve replacement will become a common treatment for aortic valve disease.

作者信息

Webb John G

机构信息

Division of Cardiology, St. Paul's Hospital, University of British Columbia, Vancouver, Canada.

出版信息

JACC Cardiovasc Interv. 2008 Apr;1(2):122-6. doi: 10.1016/j.jcin.2007.11.010.

DOI:10.1016/j.jcin.2007.11.010

PMID:19463288

Abstract

Percutaneous valve replacement is developing into an effective and reproducible therapy for aortic valve stenosis. Initial experience suggests that outcomes compare favorably with conventional valve surgery in selected patients with comorbidities, such as advanced age. Caution is prudent, however, in the future a more mature procedure might represent a viable alternative for a much broader range of patients.

摘要

经皮瓣膜置换术正在发展成为一种治疗主动脉瓣狭窄的有效且可重复的疗法。初步经验表明，在患有合并症（如高龄）的特定患者中，其治疗效果与传统瓣膜手术相比具有优势。然而，仍需谨慎，未来一种更成熟的手术方法可能会成为更广泛患者群体的可行替代方案。